Article

The effect of highly effective modulator therapy on systemic inflammation in cystic fibrosis

2024-07-27

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Despite significant clinical improvements, there is evidence of persisting airway inflammation in people with cystic fibrosis established on Elexacaftor/tezacaftor/ivacaftor (ETI) therapy. As CF is a multi-system disease, systemic immune profiles can reflect local inflammation within the lungs and other organs. Understanding systemic inflammation after ETI therapy may reveal i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ee1bf164-9c9d-573d-bf60-defb5e4a4f5b
DOI: 10.1101/2024.07.25.24310916

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The effect of highly effective modulator therapy on systemic inflammation in cystic fibrosisDOI 10.1101/2024.07.25.24310916Read

Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosisSemantic proximity Read

Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis.Semantic proximity Read

Impact of elexacaftor-tezacaftor-ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis.Semantic proximity Read

The Role of Triple CFTR Modulator Therapy in Reducing Systemic Inflammation in Cystic FibrosisSemantic proximity Read

The Impact of CFTR Modulator Triple Therapy on Type 2 Inflammatory Response in Patients with Cystic FibrosisSemantic proximity Read

Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis.Semantic proximity Read

Highly Effective Modulator Therapy: Implications for the Microbial Landscape in Cystic Fibrosis.Semantic proximity Read

Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor.Semantic proximity Read

Diagnosis and Management of Cystic Fibrosis Exacerbations.Semantic proximity Read

Pharmacological correction of CFTR improves systemic inflammation and lung disease in Cystic Fibrosis but does not correct a basic defect in lung repairSemantic proximity Read

Impact of Elexacaftor-Tezacaftor-Ivacaftor on lung disease in cystic fibrosis.Semantic proximity Read

Gene expression responses of CF airway epithelial cells exposed to elexacaftor/tezacaftor/ivacaftor (ETI) suggest benefits beyond improved CFTR channel functionSemantic proximity Read